Featured Research

from universities, journals, and other organizations

Antiviral Drugs May Help Relieve Nerve Pain Related To Shingles

Date:
May 9, 2006
Source:
JAMA and Archives Journals
Summary:
A small trial suggests that treatment with intravenous and oral antiviral medications may reduce the nerve pain that occurs following shingles, according to a study posted online today that will appear in the July 2006 print issue of Archives of Neurology, one of the JAMA/Archives journals.

A small trial suggests that treatment with intravenous and oral antiviral medications may reduce the nerve pain that occurs following shingles, according to a study posted online today that will appear in the July 2006 print issue of Archives of Neurology, one of the JAMA/Archives journals.

Related Articles


Shingles (herpes zoster) is caused by the varicella-zoster virus, the same virus that causes chickenpox, according to background information in the article. The virus lays dormant in the nervous system for decades after infection with chickenpox. When it becomes reactivated, the virus causes a rash and nerve pain (postherpetic neuralgia). Postherpetic neuralgia can that lasts for months or years and affects as many as one million people in the United States.

Dianna Quan, M.D., and colleagues at the University of Colorado and Health Sciences Center, Denver, administered antiviral therapy to 15 patients (12 men and three women) with moderate to severe nerve pain following shingles. Participants received 10 milligrams of the medication acyclovir intravenously every eight hours for 14 days and then took three 1,000-milligram pills of the medication valacyclovir per day for one month. The patients were asked to rate their pain on a scale of zero to 10 at the beginning of the study, then again after finishing each therapy and one month after finishing valacyclovir.

One month after therapy, eight (53 percent) patients reported that their pain had reduced significantly (by two or more points). This was similar to the percentage of patients who reported such an improvement after day 15 (seven) and after day 45 (eight). Most patients tolerated the treatment well, although five dropped out of the study early, three of them because of complications related to the therapy.

"Although our study was small and without placebo control, the findings suggests a promising effect of antiviral treatment on postherpetic neuralgia," the authors conclude. "Treatment of postherpetic neuralgia with IV acyclovir will be expensive. However, elimination or reduction of pain coupled with reduced burden of disease and use of health care resources would offset treatment costs."

(Arch Neurol. 2006; 63: (doi: 10.1001/archneur.63.7.noc60049). Available pre-embargo to the media at www.jamamedia.org)

Editor's Note: This study was supported in part by grants from the National Institutes of Health and a grant from the Avenir Foundation.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Cite This Page:

JAMA and Archives Journals. "Antiviral Drugs May Help Relieve Nerve Pain Related To Shingles." ScienceDaily. ScienceDaily, 9 May 2006. <www.sciencedaily.com/releases/2006/05/060508180637.htm>.
JAMA and Archives Journals. (2006, May 9). Antiviral Drugs May Help Relieve Nerve Pain Related To Shingles. ScienceDaily. Retrieved April 19, 2015 from www.sciencedaily.com/releases/2006/05/060508180637.htm
JAMA and Archives Journals. "Antiviral Drugs May Help Relieve Nerve Pain Related To Shingles." ScienceDaily. www.sciencedaily.com/releases/2006/05/060508180637.htm (accessed April 19, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, April 19, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Teen E-Cigarette Use Triples, Government Debates Regulations

Teen E-Cigarette Use Triples, Government Debates Regulations

Newsy (Apr. 19, 2015) — The Centers for Disease Control and Prevention says in 2014, 13.4 percent of high school students reported smoking an e-cigarette within 30 days. Video provided by Newsy
Powered by NewsLook.com
India's Bidi Workers Suffer for 1,000-a-Day Habit

India's Bidi Workers Suffer for 1,000-a-Day Habit

AFP (Apr. 19, 2015) — Popular because of their cheap price, bidis are the main source of income for millions of women and children who manufacture these Indian traditional cigarettes for roughly a dollar a day in dire conditions. Duration: 02:26 Video provided by AFP
Powered by NewsLook.com
Elmo Teams Up With Surgeon General To Promote Vaccinations

Elmo Teams Up With Surgeon General To Promote Vaccinations

Newsy (Apr. 18, 2015) — Surgeon General Vivek Murthy released a video with Elmo to promote vaccinations. The video was released the same day the measles outbreak ended. Video provided by Newsy
Powered by NewsLook.com
Our Love Of Puppy Dog Eyes Explained By Science

Our Love Of Puppy Dog Eyes Explained By Science

Newsy (Apr. 17, 2015) — Researchers found a spike in oxytocin occurs in both humans and dogs when they gaze into each other&apos;s eyes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins